Skip to main content
ACOG
NASDAQ Life Sciences

Alpha Cognition Grants Substantial Equity Awards to C-Suite, Including Performance-Based PSUs

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
8
Price
$5.78
Mkt Cap
$125.669M
52W Low
$3.75
52W High
$11.54
Market data snapshot near publication time

summarizeSummary

Alpha Cognition Inc. awarded significant equity compensation to its CEO, COO, and Interim CFO, including performance share units tied to ambitious stock price targets.


check_boxKey Events

  • Substantial Equity Grants to C-Suite

    The company granted significant equity awards, including restricted stock units, stock options, and performance share units, to its CEO, COO, and Interim CFO on January 9, 2026.

  • Performance Share Units (PSUs) with Ambitious Targets

    The CEO received 76,220 performance share units, which vest based on the company's stock price reaching targets up to $28.00, indicating strong management confidence in future appreciation.

  • Executive Incentive Alignment

    The compensation structure, particularly the performance-based awards, is designed to align the interests of top executives directly with long-term shareholder value creation.


auto_awesomeAnalysis

Alpha Cognition Inc. has awarded a significant equity compensation package to its Chief Executive Officer, Chief Operating Officer, and Interim Chief Financial Officer. The grants, which include restricted stock units, stock options, and performance share units, represent a substantial portion of the company's market capitalization. Notably, the CEO's performance share units are tied to ambitious stock price targets, with the highest tier vesting if the stock reaches $28.00, significantly above the current trading price. This structure strongly aligns executive incentives with long-term shareholder value creation and signals management's confidence in the company's future growth potential.

At the time of this filing, ACOG was trading at $5.78 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $125.7M. The 52-week trading range was $3.75 to $11.54. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ACOG - Latest Insights

ACOG
Apr 20, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
ACOG
Apr 14, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
8
ACOG
Apr 01, 2026, 5:18 PM EDT
Source: Reuters
Importance Score:
8
ACOG
Mar 31, 2026, 5:09 PM EDT
Filing Type: 10-K
Importance Score:
7
ACOG
Mar 26, 2026, 4:41 PM EDT
Filing Type: 8-K
Importance Score:
7
ACOG
Mar 26, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
ACOG
Mar 04, 2026, 4:05 PM EST
Filing Type: 4
Importance Score:
7
ACOG
Feb 24, 2026, 5:52 PM EST
Filing Type: 4
Importance Score:
7
ACOG
Jan 15, 2026, 5:27 PM EST
Filing Type: 8-K
Importance Score:
8